-
1دورية أكاديمية
المؤلفون: Ghose S; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, 110029, India. sampaghose@gmail.com., Roy S; Department of Radiotherapy and Oncology, All India Institute of Medical Sciences, New Delhi, India., Ghosh V; Department of Radiotherapy and Oncology, All India Institute of Medical Sciences, New Delhi, India., Sharawat SK; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, 110029, India., Pramanik R; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, 110029, India., Biswas S; Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Noida, UP, India., Biswas A; Department of Radiotherapy and Oncology, All India Institute of Medical Sciences, New Delhi, India.
المصدر: Virology journal [Virol J] 2024 Sep 20; Vol. 21 (1), pp. 224. Date of Electronic Publication: 2024 Sep 20.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium: Internet ISSN: 1743-422X (Electronic) Linking ISSN: 1743422X NLM ISO Abbreviation: Virol J Subsets: MEDLINE
مواضيع طبية MeSH: Interleukin-6*/blood , Nasopharyngeal Neoplasms*/virology , Nasopharyngeal Neoplasms*/blood , Nasopharyngeal Neoplasms*/diagnosis , Viral Load* , Herpesvirus 4, Human*/genetics , DNA, Viral*/blood , Vascular Endothelial Growth Factor A*/blood , Nasopharyngeal Carcinoma*/blood , Nasopharyngeal Carcinoma*/virology , Nasopharyngeal Carcinoma*/diagnosis , Carcinoma*/virology , Carcinoma*/blood , Carcinoma*/diagnosis , Epstein-Barr Virus Infections*/blood , Epstein-Barr Virus Infections*/virology , Epstein-Barr Virus Infections*/diagnosis, Humans ; Female ; Male ; Middle Aged ; Adult ; Prognosis ; Biomarkers/blood ; Aged ; Plasma/virology
-
2دورية أكاديمية
المؤلفون: Li JB; Department of Clinical Research, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China., Guo SS; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dong Feng East Road, Guangzhou, 510060, People's Republic of China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China., Liu T; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dong Feng East Road, Guangzhou, 510060, People's Republic of China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China., Lin ZC; Department of Medical Records, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, People's Republic of China., Gong WJ; Department of General Practice, Health Science Center, Shenzhen University, Shenzhen, 518037, People's Republic of China., Tang LQ; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dong Feng East Road, Guangzhou, 510060, People's Republic of China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China., Guo L; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dong Feng East Road, Guangzhou, 510060, People's Republic of China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China., Mo HY; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dong Feng East Road, Guangzhou, 510060, People's Republic of China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China., Mai HQ; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dong Feng East Road, Guangzhou, 510060, People's Republic of China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China., Chen QY; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dong Feng East Road, Guangzhou, 510060, People's Republic of China. chenqy@sysucc.org.cn.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China. chenqy@sysucc.org.cn.
المصدر: Radiation oncology (London, England) [Radiat Oncol] 2024 Sep 20; Vol. 19 (1), pp. 125. Date of Electronic Publication: 2024 Sep 20.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101265111 Publication Model: Electronic Cited Medium: Internet ISSN: 1748-717X (Electronic) Linking ISSN: 1748717X NLM ISO Abbreviation: Radiat Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Quality of Life* , Nasopharyngeal Carcinoma*/therapy , Nasopharyngeal Carcinoma*/mortality , Nasopharyngeal Carcinoma*/pathology , Chemoradiotherapy* , Nasopharyngeal Neoplasms*/therapy , Nasopharyngeal Neoplasms*/mortality , Nasopharyngeal Neoplasms*/pathology , Nasopharyngeal Neoplasms*/psychology, Humans ; Male ; Female ; Middle Aged ; Adult ; Prognosis ; Aged ; Longitudinal Studies ; Survival Rate ; Young Adult ; Follow-Up Studies
-
3دورية أكاديمية
المؤلفون: Zhu Y; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Shanghai, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China., Xue F; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. dr_fenxue@163.com.; Department of Oncology, Shanghai Medical College, Shanghai, China. dr_fenxue@163.com.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China. dr_fenxue@163.com.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China. dr_fenxue@163.com.
المصدر: BMC cancer [BMC Cancer] 2024 Sep 13; Vol. 24 (1), pp. 1145. Date of Electronic Publication: 2024 Sep 13.
نوع المنشور: Journal Article; Comparative Study
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Nasopharyngeal Carcinoma*/therapy , Nasopharyngeal Carcinoma*/pathology , Nasopharyngeal Carcinoma*/mortality , Nasopharyngeal Carcinoma*/drug therapy , Propensity Score* , Chemoradiotherapy*/adverse effects , Chemoradiotherapy*/methods , Nasopharyngeal Neoplasms*/therapy , Nasopharyngeal Neoplasms*/pathology , Nasopharyngeal Neoplasms*/drug therapy , Nasopharyngeal Neoplasms*/mortality , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Adult ; Aged ; Treatment Outcome ; Cisplatin/administration & dosage ; Cisplatin/therapeutic use ; Cisplatin/adverse effects ; Fluorouracil/administration & dosage ; Fluorouracil/adverse effects ; Fluorouracil/therapeutic use ; Gemcitabine ; Follow-Up Studies ; Organoplatinum Compounds
-
4دورية أكاديمية
المؤلفون: Hou J; Department of Diagnostic Radiology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya, Central South University, 283 Tongzipo Road, Yuelu District, Changsha, Hunan, 410013, P. R. China., Yi X; Department of Diagnostic Radiology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya, Central South University, 283 Tongzipo Road, Yuelu District, Changsha, Hunan, 410013, P. R. China., Li H; Department of Diagnostic Radiology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya, Central South University, 283 Tongzipo Road, Yuelu District, Changsha, Hunan, 410013, P. R. China., Lu Q; Department of Diagnostic Radiology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya, Central South University, 283 Tongzipo Road, Yuelu District, Changsha, Hunan, 410013, P. R. China., Lin H; Department of Pharmaceuticals Diagnosis, GE Healthcare, Beijing, P. R. China., Li J; Department of Pathology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, 283 Tongzipo Road, Yuelu District, Changsha, Hunan, 410013, P. R. China. lijunjun@hnca.org.cn., Zeng B; Department of Radiotherapy, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, 283 Tongzipo Road, Yuelu District, Changsha, Hunan, 410013, P. R. China. zengbiao@hnca.org.cn., Yu X; Department of Diagnostic Radiology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya, Central South University, 283 Tongzipo Road, Yuelu District, Changsha, Hunan, 410013, P. R. China. nj9015@163.com.
المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Sep 09; Vol. 150 (9), pp. 415. Date of Electronic Publication: 2024 Sep 09.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Nasopharyngeal Carcinoma*/mortality , Nasopharyngeal Carcinoma*/pathology , Nasopharyngeal Carcinoma*/diagnostic imaging , Nasopharyngeal Carcinoma*/radiotherapy , Nasopharyngeal Neoplasms*/pathology , Nasopharyngeal Neoplasms*/mortality , Nasopharyngeal Neoplasms*/diagnostic imaging , Nasopharyngeal Neoplasms*/radiotherapy , Progression-Free Survival* , Magnetic Resonance Imaging*/methods, Humans ; Male ; Female ; Middle Aged ; Adult ; Prognosis ; Aged ; Retrospective Studies ; Young Adult ; Kaplan-Meier Estimate
-
5دورية أكاديمية
المؤلفون: Liu H; Office of Cancer Screening, National Cancer Center / National Clinical Research Center for Cancer / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China., Lei L; Department of Cancer Control and Prevention, Shenzhen Center for Chronic Disease Control, Shenzhen, 518000, China., Song S; Office of Cancer Screening, National Cancer Center / National Clinical Research Center for Cancer / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China., Geng X; Office of Cancer Screening, National Cancer Center / National Clinical Research Center for Cancer / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China., Lin K; Department of Cancer Control and Prevention, Shenzhen Center for Chronic Disease Control, Shenzhen, 518000, China., Li N; Office of Cancer Screening, National Cancer Center / National Clinical Research Center for Cancer / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China., Chen W; Office of Cancer Screening, National Cancer Center / National Clinical Research Center for Cancer / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China., Peng J; Department of Cancer Control and Prevention, Shenzhen Center for Chronic Disease Control, Shenzhen, 518000, China., Ren J; Office of Cancer Screening, National Cancer Center / National Clinical Research Center for Cancer / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. ren.js@cicams.ac.cn.
المصدر: BMC cancer [BMC Cancer] 2024 Sep 07; Vol. 24 (1), pp. 1115. Date of Electronic Publication: 2024 Sep 07.
نوع المنشور: Journal Article; Meta-Analysis
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Viral*/blood , Antibodies, Viral*/immunology , Epstein-Barr Virus Infections*/immunology , Epstein-Barr Virus Infections*/diagnosis , Epstein-Barr Virus Infections*/complications , Epstein-Barr Virus Infections*/blood , Immunoglobulin A*/blood , Immunoglobulin A*/immunology , Nasopharyngeal Carcinoma*/diagnosis , Nasopharyngeal Carcinoma*/immunology , Nasopharyngeal Carcinoma*/virology , Nasopharyngeal Carcinoma*/blood , Nasopharyngeal Neoplasms*/diagnosis , Nasopharyngeal Neoplasms*/immunology , Nasopharyngeal Neoplasms*/blood , Nasopharyngeal Neoplasms*/virology, Humans ; Biomarkers, Tumor/blood ; Biomarkers, Tumor/immunology ; Early Detection of Cancer/methods ; Epstein-Barr Virus Nuclear Antigens/immunology ; Herpesvirus 4, Human/immunology ; Sensitivity and Specificity ; Serologic Tests/methods
-
6دورية أكاديمية
المؤلفون: Liu Y; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China., Ye SY; The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518033, P. R. China., He S; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China., Chi DM; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.; Department of Anesthesiology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China., Wang XZ; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China., Wen YF; Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, 510000, P. R. China., Ma D; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China., Nie RC; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China., Xiang P; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China., Zhou Y; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China., Ruan ZH; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China., Peng RJ; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China., Luo CL; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China., Wei PP; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China., Lin GW; Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510282, P. R. China., Zheng J; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China., Cui Q; Department of Pathology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, 510080, P. R. China., Cai MY; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China., Yun JP; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China., Dong J; Department of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, 510080, P. R. China., Mai HQ; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China., Xia X; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China., Bei JX; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China. beijx@sysucc.org.cn.; Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, 211103, P. R. China. beijx@sysucc.org.cn.; Division of Medical Oncology, National Cancer Centre Singapore, 30 Hospital Boulevard, 168583, Singapore, Singapore. beijx@sysucc.org.cn.
المصدر: Nature communications [Nat Commun] 2024 Sep 04; Vol. 15 (1), pp. 7713. Date of Electronic Publication: 2024 Sep 04.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
مواضيع طبية MeSH: Nasopharyngeal Carcinoma*/genetics , Nasopharyngeal Carcinoma*/immunology , Nasopharyngeal Carcinoma*/pathology , Nasopharyngeal Carcinoma*/therapy , Nasopharyngeal Carcinoma*/metabolism , Tertiary Lymphoid Structures*/immunology , Tertiary Lymphoid Structures*/genetics , Single-Cell Analysis* , Chemokine CXCL13*/metabolism , Chemokine CXCL13*/genetics , Immunotherapy*/methods , CD8-Positive T-Lymphocytes*/immunology , CD8-Positive T-Lymphocytes*/metabolism , Nasopharyngeal Neoplasms*/genetics , Nasopharyngeal Neoplasms*/immunology , Nasopharyngeal Neoplasms*/pathology , Nasopharyngeal Neoplasms*/therapy, Humans ; Gene Expression Profiling ; Disease Progression ; Transcriptome ; B-Lymphocytes/immunology ; B-Lymphocytes/metabolism ; Tumor Microenvironment/immunology ; Tumor Microenvironment/genetics ; Prognosis ; Fibroblasts/metabolism ; Fibroblasts/immunology
-
7دورية أكاديمية
المؤلفون: Kumari K; Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, India., Afroj S; Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, India., Madhry D; Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, India., Verma Y; Department of Otorhinolaryngology, All India Institute of Medical Sciences, New Delhi, India., Kairo AK; Department of Otorhinolaryngology, All India Institute of Medical Sciences, New Delhi, India., Thakar A; Department of Otorhinolaryngology, All India Institute of Medical Sciences, New Delhi, India., Sikka K; Department of Otorhinolaryngology, All India Institute of Medical Sciences, New Delhi, India., Verma H; Department of Otorhinolaryngology, All India Institute of Medical Sciences, New Delhi, India., Verma B; Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, India.
المصدر: Genes, chromosomes & cancer [Genes Chromosomes Cancer] 2024 Sep; Vol. 63 (9), pp. e23265.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9007329 Publication Model: Print Cited Medium: Internet ISSN: 1098-2264 (Electronic) Linking ISSN: 10452257 NLM ISO Abbreviation: Genes Chromosomes Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Angiofibroma*/genetics , Angiofibroma*/pathology , Exome Sequencing*/methods , Nasopharyngeal Neoplasms*/genetics , Nasopharyngeal Neoplasms*/pathology , Mutation*, Humans ; Male ; Adolescent ; Child ; Ubiquitin Thiolesterase/genetics
-
8دورية أكاديمية
المؤلفون: Wu S; Department of Oncology, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong Province, China., Peng L; Department of Radiology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, China.
المصدر: The Journal of international medical research [J Int Med Res] 2024 Sep; Vol. 52 (9), pp. 3000605241271754.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Sage Publications Country of Publication: England NLM ID: 0346411 Publication Model: Print Cited Medium: Internet ISSN: 1473-2300 (Electronic) Linking ISSN: 03000605 NLM ISO Abbreviation: J Int Med Res Subsets: MEDLINE
مواضيع طبية MeSH: Nasopharyngeal Carcinoma*/pathology , Nasopharyngeal Carcinoma*/genetics , Nasopharyngeal Carcinoma*/metabolism , Nasopharyngeal Carcinoma*/mortality , Cell Proliferation*/genetics , Nasopharyngeal Neoplasms*/pathology , Nasopharyngeal Neoplasms*/metabolism , Nasopharyngeal Neoplasms*/genetics , Nasopharyngeal Neoplasms*/mortality , Chaperonin Containing TCP-1*/metabolism , Chaperonin Containing TCP-1*/genetics , Gene Expression Regulation, Neoplastic* , Ubiquitin-Protein Ligases*/metabolism , Ubiquitin-Protein Ligases*/genetics, Humans ; Male ; Female ; Middle Aged ; Prognosis ; Cell Line, Tumor ; Biomarkers, Tumor/metabolism ; Biomarkers, Tumor/genetics ; Adult
-
9دورية أكاديمية
المؤلفون: Ma Z; The First Affiliated Hospital of Jinan University, Guangzhou, China.; Department of Otolaryngology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Chen G; Department of Otolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Li H; Department of Otolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Yang S; Department of Otolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Xu Y; Department of Otolaryngology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Pan B; Guangzhou Medical University, Guangzhou, China., Lai W; Guangzhou Medical University, Guangzhou, China., Chen G; Department of Otolaryngology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Liao W; Department of Otolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Zhang X; The First Affiliated Hospital of Jinan University, Guangzhou, China.; Department of Otolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
المصدر: Immunity, inflammation and disease [Immun Inflamm Dis] 2024 Sep; Vol. 12 (9), pp. e70005.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: John Wiley and Sons Ltd Country of Publication: England NLM ID: 101635460 Publication Model: Print Cited Medium: Internet ISSN: 2050-4527 (Electronic) Linking ISSN: 20504527 NLM ISO Abbreviation: Immun Inflamm Dis Subsets: MEDLINE
مواضيع طبية MeSH: B7 Antigens*/genetics , B7 Antigens*/metabolism , B7 Antigens*/immunology , Nasopharyngeal Carcinoma*/immunology , Nasopharyngeal Carcinoma*/pathology , Nasopharyngeal Carcinoma*/genetics , Nasopharyngeal Carcinoma*/metabolism , CD8-Positive T-Lymphocytes*/immunology , Nasopharyngeal Neoplasms*/immunology , Nasopharyngeal Neoplasms*/pathology , Nasopharyngeal Neoplasms*/genetics , Nasopharyngeal Neoplasms*/metabolism , Cell Proliferation* , Epithelial-Mesenchymal Transition*/immunology, Animals ; Humans ; Mice ; Cell Line, Tumor ; Mice, Nude ; Apoptosis ; Disease Progression ; Cell Movement ; Tumor Necrosis Factor Receptor Superfamily, Member 9/metabolism ; Tumor Necrosis Factor Receptor Superfamily, Member 9/genetics ; Tumor Necrosis Factor Receptor Superfamily, Member 9/immunology ; T-Cell Exhaustion
-
10دورية أكاديمية
المؤلفون: Chen CH; Department of Neurosurgery, China Medical University Hospital, Taichung, Taiwan, R.O.C.; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.; Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C., Chin YT; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.; Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C., Hsu SW; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.; Division of Neurosurgery, Department of Surgery, Taichung Armed Forces General Hospital, Taichung, Taiwan, R.O.C.; National Defense Medical Center, Taipei, Taiwan, R.O.C., Shih LC; Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.; Department of Otorhinolaryngology-Head and Neck Surgery, China Medical University Hospital, Taichung, Taiwan, R.O.C., Tien HC; Department of Audiology and Speech-Language Pathology, Asia University, Taichung, Taiwan, R.O.C., Tsai CW; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.; Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C., Wang YC; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.; Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C., Liu YF; Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C., Bau DT; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.; artbau2@gmail.com.; Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.; Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan, R.O.C., Chang WS; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.; halittlemelon@hotmail.com.; Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
المصدر: Anticancer research [Anticancer Res] 2024 Sep; Vol. 44 (9), pp. 3813-3820.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Matrix Metalloproteinase 8*/genetics , Nasopharyngeal Carcinoma*/genetics , Genetic Predisposition to Disease* , Nasopharyngeal Neoplasms*/genetics , Nasopharyngeal Neoplasms*/pathology , Polymorphism, Single Nucleotide*, Humans ; Male ; Female ; Middle Aged ; Case-Control Studies ; Genotype ; Adult ; Risk Factors ; Taiwan/epidemiology